InvestorsHub Logo
Followers 5
Posts 605
Boards Moderated 0
Alias Born 01/08/2009

Re: startingboy post# 385

Tuesday, 02/18/2014 5:58:07 PM

Tuesday, February 18, 2014 5:58:07 PM

Post# of 1605
"Medical, commercial and patient interest in the new drugs is intense. “Research activity is just going through the roof,” Topalian says. While Bristol-Myers Squibb, Merck and other companies rush to get their versions of the therapy approved by the Food and Drug Administration for treatment of melanoma and lung and kidney cancers, the substances also are being tested in smaller trials against cancers of the blood, colon, stomach, breast, bladder, liver, head and neck and brain. “The field is just afire now,” says immunologist Gordon Freeman of the Dana-Farber Cancer Institute in Boston."

Bingo.